Literature DB >> 1990114

The Port-A-Cath and Per-Q-Cath.

L J Hammond.   

Abstract

Venous access in acute and chronically ill patients can become problematic when attempting to maintain a reliable system. The need for safe and dependable intravascular systems has become quite evident. This article examines the Port-A-Cath (Pharmacia, Inc., St. Paul, MN) and the Per-Q-Cath (Gesco International, Inc., San Antonio, TX). These systems are preferred by several patient populations who require frequent or prolonged intravenous therapy.

Entities:  

Mesh:

Year:  1991        PMID: 1990114     DOI: 10.1016/0891-5245(91)90045-r

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  1 in total

1.  Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis.

Authors:  Maya Graham Pedersen; Søren Jensen-Fangel; Hanne Vebert Olesen; San Deep Prataprao Tambe; Eskild Petersen
Journal:  BMC Infect Dis       Date:  2015-07-27       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.